Skip to Content

Suvanza SUVZ

Morningstar Rating
$0.00 −0.05 (99.80%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

SUVZ is trading at a 718% premium.
Price
$0.05
Fair Value
$1.89
Uncertainty
Extreme
1-Star Price
$2.86
5-Star Price
$1.51
Economic Moat
Xrxtxn
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SUVZ is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.05
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.50
Market Cap
$11.20
Volume/Avg
1,255 / 1,255

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Suvanza is a biotechnology company which develops products for skin, hair, and nails diseases.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Core
Total Number of Employees
17

Valuation

Metric
SUVZ
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
SUVZ
Quick Ratio
0.23
Current Ratio
0.89
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
SUVZ
Return on Assets (Normalized)
−141.94%
Return on Equity (Normalized)
−171.33%
Return on Invested Capital (Normalized)
−170.55%
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRYwdzykfjvdPnrt$605.7 Bil
VRTX
Vertex Pharmaceuticals IncGrtyprjzClcky$116.3 Bil
REGN
Regeneron Pharmaceuticals IncKqtrqmkhKpgvsc$108.5 Bil
MRNA
Moderna IncQcxrwszSztwf$62.9 Bil
BNTX
BioNTech SE ADRWdqczjqDdpz$23.9 Bil
ARGX
argenx SE ADRWxyslbkyjQzc$21.6 Bil
ALNY
Alnylam Pharmaceuticals IncLvqhtkspSpfsk$18.9 Bil
BMRN
Biomarin Pharmaceutical IncBbfxknjpPtbvxrf$14.3 Bil
INCY
Incyte CorpMjffxzylShhlgm$12.9 Bil
UTHR
United Therapeutics CorpJnkqrhzqDdjt$12.1 Bil

Sponsor Center